Tri-Component Matrix for Cartilage Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating cartilage defects and disorders, such as osteoarthritis, often result in inadequate tissue repair with inappropriate cell types and architectural features, and lack effective regeneration of cartilage tissue.
Innovation Solution
A tri-component matrix comprising isolated and purified non-denatured type II collagen, hyaluronan, and chondroitin sulfate, combined with chondrocytes, chondroprogenitor cells, or induced pluripotent stem cells, which is implanted at the site of cartilage defects to induce endogenous cartilage growth and repair.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods for treating cartilage defects are used, then treatment can be performed, but inadequate tissue repair with inappropriate cell types and architectural features occurs
Solution Approach 1:
The patent changes the chemical and physical parameters of the matrix by using a tri-component composition (type II collagen, hyaluronan, and chondroitin sulfate) with specific concentration ratios. This creates an optimized biochemical environment that guides chondrocyte behavior and promotes formation of cartilage tissue with proper architectural features and appropriate cell types, resolving the contradiction between reliable tissue repair and manufacturing precision.
Solution Approach 2:
The patent employs a composite matrix material consisting of three specific components: type II collagen, hyaluronan, and chondroitin sulfate. This composite approach creates a synergistic effect where each component contributes specific properties that collectively support high-quality cartilage regeneration with proper architecture and cell differentiation, addressing both reliability and manufacturing precision requirements.
2Productivity
If current cartilage treatment methods are used, then treatment can be performed, but effective regeneration of cartilage tissue is lacking
Solution Approach 1:
The patent optimizes concentration parameters of matrix components (type II collagen at 1-5 mg/ml, hyaluronan at 0.1-1 mg/ml, chondroitin sulfate at 0.1-1 mg/ml) to create ideal conditions for cartilage regeneration. These parameter changes enhance the productivity of cartilage tissue generation while ensuring the repaired tissue meets reliability standards for adequate repair quality.
Solution Approach 2:
The tri-component matrix serves as an intermediary scaffold that mediates between the implanted chondrocytes and the host tissue environment. This intermediary structure provides mechanical support, biochemical signaling, and structural organization that enhances regeneration efficiency while ensuring reliable tissue repair outcomes.
3Manufacturing precision
If a tri-component matrix with specific concentrations is used, then cartilage tissue with normal structural zones is produced, but the matrix composition and preparation process becomes more complex
Solution Approach 1:
The patent establishes specific concentration ranges for each matrix component (type II collagen: 1-5 mg/ml, hyaluronan: 0.1-1 mg/ml, chondroitin sulfate: 0.1-1 mg/ml) that, when optimized, produce cartilage tissue with normal structural zones. While the composition appears complex, the defined parameter ranges provide a clear preparation protocol that achieves high manufacturing precision for structural organization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The tri-component matrix promotes the regeneration of cartilage tissue with normal structural zones, including superficial, intermediate, and deep zones, and does not include teratomas or neoplastic cells, effectively restoring cartilage surfaces and improving mechanical properties.
Implementation Method 1
The tri-component matrix promotes the regeneration of cartilage tissue with normal structural zones, including superficial, intermediate, and deep zones
Implementation Method 2
induce endogenous cartilage growth and repair
Data Source
AI summary
Provided are tri-component matrices having collagen, hyaluronan, and chondroitin sulfate. Also provided are processes for producing a tri-component matrix. Additionally, provided are processes for providing cells capable of producing cartilage to a bone or cartilage defects.